Brillet, Rozenn

Publishing since 2006 (Baby)

Has published 7 publications in 5 years

Number of publications published per year by Brillet, Rozenn. (Source : PubMed)

Distribution of publications types for Brillet, Rozenn. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Ahmed-Belkacem A, Ahnou N, Barbotte L, Wychowski C, Pallier C, Brillet R, Pohl RT, Pawlotsky JM. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.  Gastroenterology  2010;138;3  
•  Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.  PLoS ONE  2009;4;12  
•  Pallier C, Rodriguez C, Brillet R, Nordmann P, Hézode C, Pawlotsky JM. Complex dynamics of hepatitis B virus resistance to adefovir.  Hepatology  2009;49;1  
•  Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method.  Hepatology  2007;46;1  
•  Chevaliez S, Brillet R, Lázaro E, Hézode C, Pawlotsky JM. Analysis of ribavirin mutagenicity in human hepatitis C virus infection.  J. Virol.  2007;81;14  
•  Hézode C, Chevaliez S, Bouvier-Alias M, Roudot-Thoraval F, Brillet R, Zafrani ES, Dhumeaux D, Pawlotsky JM. Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.  J. Hepatol.  2007;46;5  
•  Brillet R, Penin F, Hezode C, Chouteau P, Dhumeaux D, Pawlotsky JM. The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.  J. Infect. Dis.  2007;195;3  

[ See timeline ] [ See all publications ]